Investing

ADMA Biologics : ADMA

ADMA

Stock Data

$7.97

$0.01 (0.13%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Adma Biologics Inc is a biopharmaceutical firm focused on creating plasma-derived products to fight immune deficiencies and infectious diseases. With products like BIVIGAM and ASCENIV for immune disorders, and Nabi-HB for Hepatitis B exposure, they're at the forefront of immune therapy. They also have a pipeline targeting S. pneumonia infection and run plasma collection facilities. Based in Ramsey, New Jersey, Adma Biologics sells through distributors, pharmacies, and other providers, aiming to enhance patient health globally.

All ADMA Biologics Articles

3 Articles

Omor Ibne Ehsan | May 4, 2026 at 10:57 AM EDT

Andrew Sather: Why Some Stock Buybacks Are Basically “Putting Money on Fire”

Stock buybacks have become one of the most misunderstood tools in corporate finance. On a recent episode of The Investing…

Joel South | May 3, 2026 at 9:30 AM EDT

3 Biotech Stocks to Watch for Respectable Growth Beyond AI

Artificial intelligence has dominated investor attention for two years, but biotech revenue lines are also bending sharply higher. A small…

Joshua Rodriguez | Jul 17, 2024 at 9:22 AM EDT

Add These 5 Hot Biotech Stocks In July

Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in…